HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl

HCID 38411
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
40186-72-9
Standard SMILES
Clc1cc(-c2c(Cl)c(Cl)c(Cl)c(Cl)c2Cl)c(Cl)c(Cl)c1Cl
InChIKey
JFIMDKGRGPNPRQ-UHFFFAOYSA-N
Molecular formula
C12HCl9
Average molar mass
464.2 g/mol
Monoisotopic mass
459.727499

Overview

2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl is one of 209 polychlorinated biphenyls (PCBs). PCBs are a group of synthetic organic compounds with 1-10 chlorine atoms attached to biphenyl. They were manufactured as commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4)

Names & identifiers

Preferred name
2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl
IUPAC
1,2,3,4,5-pentachloro-6-(2,3,4,5-tetrachlorophenyl)benzene
English name
2,2',3,3',4,4',5,5',6-NONACHLOROBIPHENYL
Molecular formula
C12HCl9
Molecular weight
464.21

Names & synonyms

40186-72-92,2',3,3',4,4',5,5',6-NONACHLOROBIPHENYLPCB 2062,2',3,3',4,4',5,5',6-Nonachloro-1,1'-biphenylUNII-H6G2D1WHWSH6G2D1WHWS1,1'-Biphenyl, 2,2',3,3',4,4',5,5',6-nonachloro-DTXSID50865989RefChem:53418DTXCID70814333NonachlorobiphenylNONACHLORO-1,1'-BIPHENYL
Show more names
PCB NO 206BZNO 206C20020600 PCB No. 206PCB206 in CyclohexanePCB No. 206 10 μg/mL in Isooctane2,3,4,5,6,2',3',4',5'-NonachlorobiphenylL20020600IO PCB No. 206 10μg/mLin Isooctane
53742-07-7PCB No. 2061,2,3,4,5-pentachloro-6-(2,3,4,5-tetrachlorophenyl)benzeneBiphenyl, 2,2',3,3',4,4',5,5',6-nonachloro-2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl (>80%)EINECS 258-738-6UNII-Y78YKW19VW1,1'-Biphenyl, nonachloro-

Database identifiers

CAS

Properties

Computed structural propertiesFilling in

XLogP
8.8
Topological polar surface area
0 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
0
Rotatable bonds
1
Heavy atoms
21
Formal charge
0
Complexity
351

Experimental & physicochemical properties

SpringerMaterials Properties13C nuclear magnetic resonance spectrum
LogP7.94
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section · 2 items

182.8 Ų [M-Cl+O]-

181.7 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

Physicochemical properties

Melting point
206 °C · 206°C
Boiling point
538.81 °C · 538.81°C (rough estimate)
Density
1.775 · 1.7750 (rough estimate)
refractive index
1.643 · 1.6430 (rough estimate)
solubility
Acetone (Slightly), Benzene (Slightly), DMSO (Slightly)
form
Solid
color
White to Off-White

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 7.3% (3 of 41) of reports.

Warning

H373 (92.7%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P273, P319, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Hazard Traits - Carcinogenicity; Dermatotoxicity; Developmental Toxicity; Endocrine Toxicity; Hepatotoxicity and Digestive System Toxicity; Immunotoxicity; Neurotoxicity; Reproductive Toxicity

Substance: Nonachloro-1,1'-biphenyl

Hazard Classes and CategoriesSTOT RE 2 (92.7%)

Safety & protection

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

Toxicology

Treatment · 1 item

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 item

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

Uses & manufacturing

Uses · 1 item

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

Applications

Uses2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

Upstream & downstream products

Upstream raw materials

Benzene, 1,2,3,4-tetrachloro-5-iodo-2,3,4,5-TETRACHLOROANILINE1,2,3,4,5-PENTACHLORO-6-IODOBENZENEPENTACHLOROBENZENE

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
40186-72-9、53742-07-7
PubChem CID
38411
DTXSID
DTXSID50865989
UNII
H6G2D1WHWS
EC Number
258-738-6、630-490-7
Nikkaji
J150.416I
Water Solubility
0.02549 ug/L · 0.02549ug/L(25 ºC)
Henry's Law Constant
2.1 · 2.1×10-3 mol/(m3Pa) at 25℃, Paasivirta and Sinkkonen (2009)
CAS DataBase Reference
40186 · 40186-72-9
FDA UNII
6 G2D1WHWS · H6G2D1WHWS
EPA Substance Registry System
2 · 2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl (40186-72-9)
Symbol(GHS)
8 · GHS08,GHS09
Signal word
Warning
Hazard statements
410 · H410-H373
Precautionary statements
273 · P273-P391-P501-P260-P314-P501

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Exposure RoutesOral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 item

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

Safety data

Signal word
Warning
Symbol(GHS)
GHS08,GHS09
Hazard statements
H410-H373
Precautionary statements
P273-P391-P501-P260-P314-P501

Downstream products

3,3',4,4',5,5'-HEXACHLOROBIPHENYL2,4,4'-TRICHLOROBIPHENYL